Modifying Material Surfaces for Biomedical Applications
In this piece, Erik Lamoureux introduces the unique challenges associated with biomaterial surface modifications in a biomedical setting, and a recent publication on studies by the Kizhakkedathu group.
Research That Makes You Want to Smile: Novel Role for Granzyme B in Periodontal Inflammation
Researchers in the Kim lab have discovered a new role for serine protease Granzyme B (GzmB).
The Discovery of New Sentinels on the Immune Watchtower for Cancer
In the latest study by the Jefferies lab, we delve into the intricate world of type-2 innate lymphoid cells (ILC2), specifically exploring their plasticity during tumour expansion .
Hotwire the Cure: Turning Cold Tumors Hot
Research by Dr. Julyanne Brassard, recently published in Frontiers in Oncology, highlights a promising new therapeutic target for ovarian cancer.
Pain Amplified: Revealing the High Levels of Chronic Pain Among Women Living with HIV
A recent publication by members of the Côté Lab, explores articles published in the last 40 years that investigated pain in WLWH.
CD248 Promotes Insulin Resistance by Binding to the Insulin Receptor and Dampening Its Insulin-Induced Autophosphorylation
Science in Vancouver profiled a recent publication in EBioMedicine from the laboratory of Dr. Edward Conway.
The Clinical Implications of the Connection between COVID-19 and Sepsis
Two recent studies by the Hancock Lab1,2, focus on severe COVID-19 and another infectious disease called sepsis.
How superbugs get their superpowers
A recent study led by UBC researchers in the Strynadka lab is shedding light on how one of the world’s most notorious superbugs, Staphylococcus aureus (S. aureus), develops resistance to antibiotics.
Lipid Nanoparticle Freight Comparison
The Kastrup group compared the effects of two ionizable cations lipids for RNA therapies targeting the liver
Jefferies Lab publication “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”
Publication from Dr. Jefferies Lab: “A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours”Published: May 15, 2023 https://doi.org/10.3389/fphar.2023.1119607